Actinium-225, an alpha-emitting radiopharmaceutical, targets cancer cells precisely, sparing healthy tissue, and is being trialed for advanced breast cancer in the U.S. The phase 1b/2 trial involves ...
Roger Jackson, 80, from Bedford, had the incisionless treatment for liver cancer and was discharged the next day [Cambridge University Hospitals NHS Foundation Trust] A hospital has become the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results